Inhibition of Osteoclast Differentiation and Bone Resorption byN-Methylpyrrolidone

α-Tocotrienol inhibits osteoclastic bone resorption by suppressing RANKL expression and signaling and bone resorbing activity

(2011) Hyunil Ha et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Impact of Bisphosphonates on the Risk of Atrial Fibrillation

(2010) Patricia A. Howard et al.   American Journal of Cardiovascular Drugs

Macrophage inflammatory protein-1α induces osteoclast formation by activation of the MEK/ERK/c-Fos pathway and inhibition of the p38MAPK/IRF-3/IFN-β pathway

(2010) Masanobu Tsubaki et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

cAMP enhances BMP2-signaling through PKA and MKP1-dependent mechanisms

(2009) Chafik Ghayor et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Evidence for anti-osteoporosis therapy in acute fracture situations—Recommendations of a multidisciplinary workshop of the International Society for Fracture Repair

(2009) J. Goldhahn et al.   BONE

N-Methyl Pyrrolidone as a Potent Bone Morphogenetic Protein Enhancer for Bone Tissue Regeneration

(2009) Blanca San Miguel et al.   TISSUE ENGINEERING PART A

Cathepsin K Activity-dependent Regulation of Osteoclast Actin Ring Formation and Bone Resorption

(2008) Susan R. Wilson et al.   JOURNAL OF BIOLOGICAL CHEMISTRY